Mirum Pharmaceuticals Inc

NASDAQ:MIRM 4:00:00 PM EDT

38.75

-0.51 (-1.30%)

: $38.32 -0.43 (-1.11%)

Market Cap (Intraday)	1.85B
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$81.54 Million
Adjusted EPS	-$0.43

See more estimates

10-Day MA	$39.37
50-Day MA	$40.60
200-Day MA	$31.50

See more pivots

Mirum Pharmaceuticals Inc Stock, NASDAQ:MIRM

989 East Hillsdale Boulevard, Suite 300, Foster City, California 94404

United States of America

Phone: +1.650.667.4085

Number of Employees: 264

http://www.mirumpharma.com

Description

Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. The firm focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. Its products include Maralixibat and Volixibat. The company was founded by Niall O'Donnel, Michael Grey and Christopher Peetz in May 2018 and is headquartered in Foster City, CA.